Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Prehospital ticagrelor in ST-segment elevation myocardial infarction

New England Journal of Medicine, Volume 371, No. 11, Year 2014

BACKGROUND The direct-acting platelet P2Y12 receptor antagonist ticagrelor can reduce the incidence of major adverse cardiovascular events when administered at hospital admission to patients with ST-segment elevation myocardial infarction (STEMI). Whether prehospital administration of ticagrelor can improve coronary reperfusion and the clinical outcome is unknown.

Statistics
Citations: 317
Authors: 27
Affiliations: 21
Identifiers
Research Areas
Health System And Policy
Noncommunicable Diseases
Study Design
Cohort Study